Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 29693170)

  • 21. CBX8 and CD96 Are Important Prognostic Biomarkers of Colorectal Cancer.
    Song X; Tang T; Li C; Liu X; Zhou L
    Med Sci Monit; 2018 Nov; 24():7820-7827. PubMed ID: 30383736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Weighted gene coexpression analysis indicates that PLAGL2 and POFUT1 are related to the differential features of proximal and distal colorectal cancer.
    Lv Y; Xie B; Bai B; Shan L; Zheng W; Huang X; Zhu H
    Oncol Rep; 2019 Dec; 42(6):2473-2485. PubMed ID: 31638246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integrated regulatory mechanisms of miRNAs and targeted genes involved in colorectal cancer.
    Wang J; Yu H; Ye L; Jin L; Yu M; Lv Y
    Int J Clin Exp Pathol; 2015; 8(1):517-29. PubMed ID: 25755742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of NOX Family Genes and Their Clinical Significance in Colorectal Cancer.
    Cho SY; Kim JS; Eun HS; Kang SH; Lee ES; Kim SH; Sung JK; Lee BS; Jeong HY; Moon HS
    Dig Dis Sci; 2018 Sep; 63(9):2332-2340. PubMed ID: 29781053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of 6 Hub Proteins and Protein Risk Signature of Colorectal Cancer.
    Yue T; Liu C; Zhu J; Huang Z; Guo S; Zhang Y; Xu H; Liu Y; Wang P; Chen S
    Biomed Res Int; 2020; 2020():6135060. PubMed ID: 33376727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Large-Scale Analysis of Gene Expression Data Reveals a Novel Gene Expression Signature Associated with Colorectal Cancer Distant Recurrence.
    Alajez NM
    PLoS One; 2016; 11(12):e0167455. PubMed ID: 27935967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gab2 is a novel prognostic factor for colorectal cancer patients.
    Ding C; Luo J; Yu W; Gao S; Yang L; Chen C; Feng J
    Int J Clin Exp Pathol; 2015; 8(3):2779-86. PubMed ID: 26045784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Three Potential Tumor Markers Promote Metastasis and Recurrence of Colorectal Cancer by Regulating the Inflammatory Response: ADAM8, LYN, and S100A9.
    Liu J; Li J; Du H; Xu L; Yang Z; Yuan M; Zhang K; Li J; Xing W; Wang S; Hu T; Wang J; Wang J; Gong Q
    Comput Math Methods Med; 2022; 2022():3118046. PubMed ID: 35103068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low expression of RASSF10 is associated with poor survival in patients with colorectal cancer.
    Wang F; Li P; Feng Y; Hu YL; Liu YF; Guo YB; Jiang XL; Mao QS; Xue WJ
    Hum Pathol; 2017 Apr; 62():108-114. PubMed ID: 28041974
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genome-Wide Network-Based Analysis of Colorectal Cancer Identifies Novel Prognostic Factors and an Integrative Prognostic Index.
    Hou X; He X; Wang K; Hou N; Fu J; Jia G; Zuo X; Xiong H; Pang M
    Cell Physiol Biochem; 2018; 49(5):1703-1716. PubMed ID: 30248669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of four novel hub genes as monitoring biomarkers for colorectal cancer.
    Luo D; Yang J; Liu J; Yong X; Wang Z
    Hereditas; 2022 Jan; 159(1):11. PubMed ID: 35093172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CYP24A1 is a potential biomarker for the progression and prognosis of human colorectal cancer.
    Sun H; Wang C; Hao M; Sun R; Wang Y; Liu T; Cong X; Liu Y
    Hum Pathol; 2016 Apr; 50():101-8. PubMed ID: 26997443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A 63 signature genes prediction system is effective for glioblastoma prognosis.
    Zhang Y; Xu J; Zhu X
    Int J Mol Med; 2018 Apr; 41(4):2070-2078. PubMed ID: 29393370
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of COL6A3 in colorectal cancer.
    Liu W; Li L; Ye H; Tao H; He H
    Oncol Rep; 2018 Jun; 39(6):2527-2536. PubMed ID: 29620224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening for implicated genes in colorectal cancer using whole‑genome gene expression profiling.
    Sun LC; Qian HX
    Mol Med Rep; 2018 Jun; 17(6):8260-8268. PubMed ID: 29658574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Downregulation of DHRS9 expression in colorectal cancer tissues and its prognostic significance.
    Hu L; Chen HY; Han T; Yang GZ; Feng D; Qi CY; Gong H; Zhai YX; Cai QP; Gao CF
    Tumour Biol; 2016 Jan; 37(1):837-45. PubMed ID: 26254099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protein-protein interaction networks and modules analysis for colorectal cancer and serrated adenocarcinoma.
    Yu H; Ye L; Wang J; Jin L; Lv Y; Yu M
    J Cancer Res Ther; 2015; 11(4):846-51. PubMed ID: 26881529
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integrating proteomics and transcriptomics for the identification of potential targets in early colorectal cancer.
    Yang W; Shi J; Zhou Y; Liu T; Zhan F; Zhang K; Liu N
    Int J Oncol; 2019 Aug; 55(2):439-450. PubMed ID: 31268166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification and characterization of ANO9 in stage II and III colorectal carcinoma.
    Li C; Cai S; Wang X; Jiang Z
    Oncotarget; 2015 Oct; 6(30):29324-34. PubMed ID: 26317553
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proteomics analysis of differential protein expression identifies heat shock protein 47 as a predictive marker for lymph node metastasis in patients with colorectal cancer.
    Mori K; Toiyama Y; Otake K; Fujikawa H; Saigusa S; Hiro J; Kobayashi M; Ohi M; Tanaka K; Inoue Y; Kobayashi Y; Kobayashi I; Mohri Y; Goel A; Kusunoki M
    Int J Cancer; 2017 Mar; 140(6):1425-1435. PubMed ID: 27925182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.